T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Aurora
AUR
$13.5B
| $177M | 0.02% |
26,329,316
-342,003
| -1% | -$2.45M |
|
452
Illinois Tool Works
ITW
$82.5B
| $175M | 0.02% |
707,240
-160,007
| -18% | -$41.1M |
|
453
Moody's
MCO
$82.6B
| $172M | 0.02% |
369,778
+4,617
| +1% | +$2.22M |
|
|
SLNO
454
DELISTED
Soleno Therapeutics
SLNO
| $172M | 0.02% |
2,400,418
+769,700
| +47% | +$37.5M |
|
455
Crinetics Pharmaceuticals
CRNX
$8.96B
| $171M | 0.02% |
5,112,360
-302,145
| -6% | -$11.3M |
|
456
Neurocrine Biosciences
NBIX
$15.5B
| $170M | 0.02% |
1,539,601
+49,088
| +3% | +$6.22M |
|
457
Alamos Gold
AGI
$13.7B
| $170M | 0.02% |
6,359,396
-279,346
| -4% | -$6.3M |
|
458
Marqeta
MQ
$1.65B
| $169M | 0.02% |
10,274,293
+5,732,017
| +126% | +$90.4M |
|
459
Teck Resources
TECK
$31.6B
| $169M | 0.02% |
4,639,763
-526,165
| -10% | -$21.8M |
|
460
Millicom
TIGO
$16B
| $169M | 0.02% |
5,578,894
+5,470,214
| +5,033% | +$151M |
|
|
BA.PRA
461
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.14B
| – | – |
0
| – | – |
|
462
FedEx
FDX
$78.8B
| $167M | 0.02% |
685,883
+1,293
| +0.2% | +$335K |
|
463
Emerson Electric
EMR
$89.5B
| $167M | 0.02% |
1,523,931
+11,095
| +0.7% | +$1.34M |
|
464
Tidewater
TDW
$4.54B
| $165M | 0.02% |
3,904,826
+1,598,513
| +69% | +$79.5M |
|
465
Mine Safety
MSA
$7.3B
| $165M | 0.02% |
1,122,450
-9,065
| -0.8% | -$1.44M |
|
466
Pultegroup
PHM
$24.8B
| $162M | 0.02% |
1,579,792
+276,077
| +21% | +$29.8M |
|
467
Tyler Technologies
TYL
$12.9B
| $162M | 0.02% |
279,052
-13,084
| -4% | -$7.77M |
|
468
Johnson Controls International
JCI
$92.2B
| $162M | 0.02% |
2,023,471
+143,825
| +8% | +$11.8M |
|
469
Motorola Solutions
MSI
$76.6B
| $161M | 0.02% |
368,828
-295,357
| -44% | -$132M |
|
470
Eaton
ETN
$176B
| $161M | 0.02% |
593,686
+718
| +0.1% | +$224K |
|
471
Duke Energy
DUK
$96.9B
| $161M | 0.02% |
1,317,476
-72,516
| -5% | -$8.27M |
|
472
Ameriprise Financial
AMP
$49.7B
| $161M | 0.02% |
331,755
+10,478
| +3% | +$5.5M |
|
473
Kanzhun
BZ
$6.9B
| $160M | 0.02% |
8,325,904
+1,970,441
| +31% | +$32.1M |
|
474
Biogen
BIIB
$31.1B
| $158M | 0.02% |
1,151,192
-782,524
| -40% | -$112M |
|
475
Flowers Foods
FLO
$1.58B
| $157M | 0.02% |
8,252,471
+15,679
| +0.2% | +$300K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.